Chembio diagnostics, Inc.
CEMI
CEMI was delisted on the 27th of April, 2023.
26 hedge funds and large institutions have $15M invested in Chembio diagnostics, Inc. in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 4 closing their positions.
233% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 3
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
60% more capital invested
Capital invested by funds: $9.38M → $15M (+$5.64M)
24% more funds holding
Funds holding: 21 → 26 (+5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
+$1.03M |
| 2 |
BCCM
Blue Clay Capital Management
Minneapolis,
Minnesota
|
+$359K |
| 3 |
Renaissance Technologies
New York
|
+$267K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$179K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$173K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Moors & Cabot
Boston,
Massachusetts
|
-$201K |
| 2 |
TAM
Taurus Asset Management
New York
|
-$88.3K |
| 3 |
SLG
Stanley-Laman Group
Berwyn,
Pennsylvania
|
-$68K |
| 4 |
Neuberger Berman Group
New York
|
-$60K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$23.4K |
CEMI Hedge Fund Activity: Q2 2016 in Review
26 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q2 2016, worth a combined $15M — up 60% from $9.38M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new CEMI positions and 4 closed out — a net gain of 5 holders — while 10 added to existing stakes and 3 trimmed.
The largest buyer was EAM Investors, opening a new position worth an estimated $1.03M. The largest seller was Moors & Cabot, exiting entirely with an estimated $201K sold.
- 26 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q2 2016, up from 21 in Q1 2016.
- Funds reported $15M of Chembio diagnostics, Inc. stock for Q2 2016, up 60% quarter-over-quarter.
- 9 funds opened new Chembio diagnostics, Inc. positions in Q2 2016 and 4 closed out, a net change of +5 holders.
- The largest Chembio diagnostics, Inc. buyer in Q2 2016 was EAM Investors, an estimated $1.03M added.
- The largest Chembio diagnostics, Inc. seller in Q2 2016 was Moors & Cabot, an estimated $201K sold.
Based on aggregated 13F filings for Q2 2016.